This federal contract award, identified as SPE2DB22D1002|SPE2DB25FKUZ7, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,678.19 firm fixed-price delivery order is for the supply of 4,566,597,194 units of the medication teriparatide 600 mcg/2.4 ml pen. This award does not have a set-aside designation, indicating open competition.
The contract is a delivery order placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. In addition, AmerisourceBergen holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These strategic IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Generated 3/4/25, 11:26 AM